Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 expresses a microRNA-like small RNA able to selectively repress host genes
Paulina Pawlica, Therese A. Yario, Sylvia S. White, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 52
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Non-coding RNAs in disease: from mechanisms to therapeutics
Kinga Németh, Recep Bayraktar, Manuela Ferracin, et al.
Nature Reviews Genetics (2023) Vol. 25, Iss. 3, pp. 211-232
Closed Access | Times Cited: 297
SARS-CoV-2 impairs interferon production via NSP2-induced repression of mRNA translation
Xu Zhang, Jung‐Hyun Choi, David L. Dai, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 32
Open Access | Times Cited: 57
The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review
Sujay Paul, Luis Alberto Bravo-Vázquez, Paula Reyes‐Pérez, et al.
Virus Research (2021) Vol. 308, pp. 198631-198631
Open Access | Times Cited: 56
A virus‐derived microRNA targets immune response genes during SARS‐CoV‐2 infection
Meetali Singh, Maxime Chazal, Piergiuseppe Quarato, et al.
EMBO Reports (2021) Vol. 23, Iss. 2
Open Access | Times Cited: 44
MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies
Mamta Panda, Elora Kalita, Satyendra Singh, et al.
Life Sciences (2022) Vol. 305, pp. 120761-120761
Open Access | Times Cited: 36
Comprehensive review for non-coding RNAs: From mechanisms to therapeutic applications
Yanjun Zhang, Lijuan Zhan, Xue Jiang, et al.
Biochemical Pharmacology (2024) Vol. 224, pp. 116218-116218
Closed Access | Times Cited: 6
Subsequent Waves of Convergent Evolution in SARS-CoV-2 Genes and Proteins
Daniele Focosi, Pietro Giorgio Spezia, Fabrizio Maggi
Vaccines (2024) Vol. 12, Iss. 8, pp. 887-887
Open Access | Times Cited: 5
Alzheimer’s disease and infectious agents: a comprehensive review of pathogenic mechanisms and microRNA roles
Seyyed Sam Mehdi Hosseininasab, Rasoul Ebrahimi, Shirin Yaghoobpoor, et al.
Frontiers in Neuroscience (2025) Vol. 18
Open Access
Reduced Presence of SARS-CoV-2 microRNA-like Small RNA in the Serum of Patients with Post-Acute Sequelae SARS-CoV-2 Infection
Maria Alfreda Stincarelli, Isabella Abbate, Giulia Matusali, et al.
Microorganisms (2025) Vol. 13, Iss. 1, pp. 126-126
Open Access
COVID−19, Anti-NMDA Receptor Encephalitis and MicroRNA
Hsiuying Wang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
Scalable and deep profiling of mRNA targets for individual microRNAs with chimeric eCLIP
Sergei A. Manakov, Alexander A. Shishkin, Brian A. Yee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 23
The SARS-CoV-2 protein NSP2 impairs the silencing capacity of the human 4EHP-GIGYF2 complex
Limei Zou, Clara Moch, Marc Graille, et al.
iScience (2022) Vol. 25, Iss. 7, pp. 104646-104646
Open Access | Times Cited: 22
Genomic surveillance of SARS-CoV-2 positive passengers on flights from China to Italy, December 2022
Federica Novazzi, Emanuela Giombini, Martina Rueca, et al.
Eurosurveillance (2023) Vol. 28, Iss. 2
Open Access | Times Cited: 13
Bioinformatics approaches for unveiling virus-host interactions
Hitoshi Iuchi, Junna Kawasaki, Kento Kubo, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 1774-1784
Open Access | Times Cited: 13
miRNAs: The Key Regulator of COVID-19 Disease
Leyla Tahrani Hardin, Nan Xiao
International Journal of Cell Biology (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 20
Translational Control of COVID-19 and Its Therapeutic Implication
Dejiu Zhang, Lei Zhu, Yin Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Emerging role of microRNAs and long non-coding RNAs in COVID-19 with implications to therapeutics
Kaifee Arman, Zeinab Dalloul, Esra Bozgeyik
Gene (2023) Vol. 861, pp. 147232-147232
Open Access | Times Cited: 11
Identification of the viral and cellular microRNA interactomes during SARS-CoV-2 infection
Nicolas Fossat, Emma A. Lundsgaard, Rui Costa, et al.
Cell Reports (2023) Vol. 42, Iss. 4, pp. 112282-112282
Open Access | Times Cited: 11
SARS-CoV-2-encoded small RNAs are able to repress the host expression of SERINC5 to facilitate viral replication
Salvador Meseguer, Mari‐Paz Rubio, Begoña Lainez, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 8
Plasma miR-195-5p predicts the severity of Covid-19 in hospitalized patients
Alexandra Ioana Moatăr, Aimée Rodica Chiş, Mirabela Romanescu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
The impact of non-synonymous mutations on miRNA binding sites within the SARS-CoV-2 NSP3 and NSP4 genes
Seyed Mohammad Ali Hosseini Rad, Dhammika Leshan Wannigama, Nattiya Hirankarn, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
The SARS-CoV-2 protein NSP2 enhances microRNA-mediated translational repression
Parisa Naeli, Xu Zhang, Patric Harris Snell, et al.
Journal of Cell Science (2023) Vol. 136, Iss. 19
Open Access | Times Cited: 7
Mechanisms of impairment of interferon production by SARS-CoV-2
Huy‐Dung Hoang, Parisa Naeli, Tommy Alain, et al.
Biochemical Society Transactions (2023) Vol. 51, Iss. 3, pp. 1047-1056
Open Access | Times Cited: 6
The RNA Interference Effector Protein Argonaute 2 Functions as a Restriction Factor Against SARS-CoV-2
Joaquín López-Orozco, Nawell Fayad, Juveriya Qamar Khan, et al.
Journal of Molecular Biology (2023) Vol. 435, Iss. 16, pp. 168170-168170
Open Access | Times Cited: 6
Native RNA Purification Method for Small RNA Molecules Based on Asymmetrical Flow Field-Flow Fractionation
Alesia A. Levanova, Mirka Lampi, Kiira Kalke, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 261-261
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top